<!doctype html><html lang=en data-theme><head><title>彤炜加油 | 儿童非转移性横纹肌肉瘤分层治疗的疗效及预后影响因素分析</title><meta charset=utf-8><meta name=generator content="Hugo 0.76.5"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover"><meta name=description content="静女其娈/贻我彤管/彤管有炜/说怿女美"><link rel=stylesheet href=https://tongweijiayou.com/css/style.min.db0abd96b425c176a3a5e8ea6028f0dbe50e3a7116e55a6ef1584d59a0ea9516.css integrity="sha256-2wq9lrQlwXajpejqYCjw2+UOOnEW5Vpu8VhNWaDqlRY=" crossorigin=anonymous type=text/css><link href=https://stackpath.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css rel=stylesheet integrity=sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN crossorigin=anonymous><link rel="shortcut icon" href=https://tongweijiayou.com/favicons/favicon.ico type=image/x-icon><link rel=apple-touch-icon sizes=180x180 href=https://tongweijiayou.com/favicons/apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=https://tongweijiayou.com/favicons/favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=https://tongweijiayou.com/favicons/favicon-16x16.png><link rel=canonical href=https://tongweijiayou.com/docs/%E5%84%BF%E7%AB%A5%E9%9D%9E%E8%BD%AC%E7%A7%BB%E6%80%A7%E6%A8%AA%E7%BA%B9%E8%82%8C%E8%82%89%E7%98%A4%E5%88%86%E5%B1%82%E6%B2%BB%E7%96%97%E7%9A%84%E7%96%97%E6%95%88%E5%8F%8A%E9%A2%84%E5%90%8E%E5%BD%B1%E5%93%8D%E5%9B%A0%E7%B4%A0%E5%88%86%E6%9E%90/><script type=text/javascript src=https://tongweijiayou.com/js/anatole-header.min.e782db136ec18d105a4552702eac49f4620d6867da3fbf808bd53e806c96be6e.js integrity="sha256-54LbE27BjRBaRVJwLqxJ9GINaGfaP7+Ai9U+gGyWvm4=" crossorigin=anonymous></script></head><body><div class="sidebar animated fadeInDown"><div class=logo-title><div class=title><img src=https://tongweijiayou.com/images/profile.jpg alt="profile picture"><h3><a href=/>彤炜加油</a></h3><div class=description><p>静女其娈/贻我彤管/彤管有炜/说怿女美</p></div></div></div><div class=footer><div class=by_farbox>&copy; Tone Well 2021</div></div></div><div class=main><div class="page-top animated fadeInDown"><a role=button class=navbar-burger data-target=navMenu aria-label=menu aria-expanded=false><span aria-hidden=true></span><span aria-hidden=true></span><span aria-hidden=true></span></a><ul class=nav id=navMenu><li><a href=/>首页</a></li><li><a href=/daily/>日记</a></li><li><a href=/files/>档案</a></li><li><a href=/docs/>资料</a></li><li><a href=/bookmarks/>书签</a></li><li><a href=/about/>关于</a></li><li class=theme-switch-item><a class=theme-switch title="Switch Theme"><i class="fa fa-adjust fa-fw" aria-hidden=true></i></a></li></ul></div><div class=autopagerize_page_element><div class=content><div class="post animated fadeInDown"><div class=post-content><div class=post-title><h1>儿童非转移性横纹肌肉瘤分层治疗的疗效及预后影响因素分析</h1></div><p><a href="http://rs.yiigle.com/resource_static.jspx?contentId=1160583">http://rs.yiigle.com/resource_static.jspx?contentId=1160583</a></p><h2 id=摘要>摘要</h2><p><strong>目的</strong></p><p>分析儿童非转移性横纹肌肉瘤(RMS)分层治疗的疗效及预后影响因素。</p><p><strong>方法</strong></p><p>研究对象为2005年1月至2016年12月上海交通大学医学院附属上海儿童医学中心新诊断的非转移性RMS患儿，共129例。根据RMS术前、术后分期及病理类型将患儿分为低危组、中危组和高危组，综合治疗方案包括根据分组采用不同强度化疗、放疗治疗及适时肿瘤根治性切除术。采用Kaplan－Meier生存分析法对RMS进行生存率及影响因素分析。</p><p><strong>结果</strong></p><p>129例患儿中，最终119例进入统计，发病年龄7～191个月，中位发病年龄48个月，无事件患儿中位随访时间40个月，所有患儿中位随访时间36个月。实际分组中低危组8例，中危组49例，高危组62例。5年总体生存(OS)率为(92.1±2.9)%，5年无事件生存(EFS)率为(76.5± 4.4)%；低危组、中危组及高危组患儿5－EFS均>70%，但组间比较差异无统计学意义(<em>χ</em>2＝2.679，<em>P</em>＝0.262)；单因素分析发现：发病年龄≤1岁或≥10岁、术前分期、早期手术完整切除明显影响预后，差异均有统计学意义(均<em>P</em>&lt;0.05)，而性别、病理分型、原发部位与EFS无明显相关性(均<em>P</em>>0.05)。腺泡型RMS(ARMS)患儿中叉头转录因子1(<em>FOXO1</em>)阳性者5－EFS明显低于<em>FOXO1</em>阴性者[(56.3±14.8)%比(83.3%±15.2)%]，差异有统计学意义(<em>χ</em>2＝4.588，<em>P</em>＝0.028)。</p><p><strong>结论</strong></p><p>RMS治疗需严格做好危险度分组；低危组相对中危组预后较差，方案需改进；中危组患儿可考虑优化化疗药物并适度减轻化疗剂量；<em>FOXO1</em>阳性可纳入危险度分组中进行分层治疗。</p></div><div class=post-footer><div class=info></div></div></div></div></div></div><script type=text/javascript src=https://tongweijiayou.com/js/jquery.min.86b1e8f819ee2d9099a783e50b49dff24282545fc40773861f9126b921532e4c.js integrity="sha256-hrHo+BnuLZCZp4PlC0nf8kKCVF/EB3OGH5EmuSFTLkw=" crossorigin=anonymous></script><script type=text/javascript src=https://tongweijiayou.com/js/bundle.min.0f9c74cb78f13d1f15f33daff4037c70354f98acfbb97a6f61708966675c3cae.js integrity="sha256-D5x0y3jxPR8V8z2v9AN8cDVPmKz7uXpvYXCJZmdcPK4=" crossorigin=anonymous></script><script type=text/javascript src=https://tongweijiayou.com/js/medium-zoom.min.92f21c856129f84aeb719459b3e6ac621a3032fd7b180a18c04e1d12083f8aba.js integrity="sha256-kvIchWEp+ErrcZRZs+asYhowMv17GAoYwE4dEgg/iro=" crossorigin=anonymous></script></body></html>